Recalling firm
Meitheal Pharmaceuticals, Inc
Product type
Drug
Status
Ongoing
Report date
2026-02-18
Distribution
U.S. Nationwide
Firm state
IL
Product quantity
16,477 kits
Initiated by
Voluntary: Firm initiated
Reason for recall
Defective Delivery System: Missing or duplicated needles within the injection kit
Product description
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Code / lot info
Lot Q4E0112A, Exp.: 30 Apr 2027
Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.